©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Nov 18, 2024; 15(11): 1095-1100
Published online Nov 18, 2024. doi: 10.5312/wjo.v15.i11.1095
Published online Nov 18, 2024. doi: 10.5312/wjo.v15.i11.1095
Metagenomic next-generation sequencing may assist diagnosis of osteomyelitis caused by Mycobacterium houstonense: A case report
Hong-Yin Lin, Quan-Hui Tan, Department of Infectious Disease, Shanghai Sixth People's Hos
Author contributions: Tan QH and Lin HY collaboratively collected data and authored this paper.
Supported by The National Natural Science Foundation of China , No. 82100631 .
Informed consent statement: The issuance of this article was granted informed consent by the patient.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Quan-Hui Tan, PhD, Academic Research, Department of Infectious Disease, Shanghai Sixth People’s Hospital, No. 600 Yishan Road, Xuhui District, Shanghai 200233, China. tanquanhui@sina.cn
Received: May 5, 2024
Revised: August 22, 2024
Accepted: September 23, 2024
Published online: November 18, 2024
Processing time: 194 Days and 4.3 Hours
Revised: August 22, 2024
Accepted: September 23, 2024
Published online: November 18, 2024
Processing time: 194 Days and 4.3 Hours
Core Tip
Core Tip: Both the diagnosis and treatment of Mycobacterium houstonense osteomyelitis are challenging for clinicians, and metagenomic next-generation sequencing serves as an important complementary diagnostic tool for individuals with compromised immune systems who may have osteomyelitis, especially when traditional diagnostic methods are uncertain.